The Perelman School of Medicine, commonly known as Penn Med, is the medical school of the University of Pennsylvania. It is located in the University City section of Philadelphia.

During the past decade, University of Pennsylvania School of Medicine conducted 70 clinical trials. In the 10-year time frame, 70 clinical trials started and 18 clinical trials were completed, i.e. on average, 25.7% percent of trials that started reached the finish line to date. In the past 5 years, 44 clinical trials started and 10 clinical trials were completed. i.e. 22.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Pennsylvania School of Medicine" #1 sponsor was "University of Pennsylvania" with 35 trials, followed by "Janssen Research & Development, LLC" with 7 trials sponsored, "Cytokinetics" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pennsylvania School of Medicine" #1 collaborator was "University of Pennsylvania" with 7 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 3 trials as a collaborator. Other collaborators include 45 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "University of Pennsylvania School of Medicine" are "Alcohol Drinking" (4 trials), "Obesity" (4 trials), "Colorectal Cancer" (3 trials), "Depressive Disorder, Major" (3 trials) and "Adenomatous Polyposis Coli" (2 trials). Many other conditions were trialed in "University of Pennsylvania School of Medicine" in a lesser frequency.

Most popular intervention types in "University of Pennsylvania School of Medicine" are "Drug" (67 trials), "Other" (17 trials), "Behavioral" (16 trials), "Biological" (5 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "10-1074-LS" (2 trials), "3BNC117-LS" (2 trials), "Atezolizumab" (2 trials) and "Aticaprant" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Pennsylvania School of Medicine" are 98 trials for "All" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "University of Pennsylvania School of Medicine". undefined are not yet recruiting, 30 are recruiting, 10 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 45 completed trials in University of Pennsylvania School of Medicine, 3 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in University of Pennsylvania School of Medicine, 16 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 19 trials that are defined as “Not Applicable".